DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Agnelli G, Gussoni G, Bianchini C. et al. PROTECHT Investigators.
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.
Lancet Oncol 2009;
10 (10) 943-949
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.